Double-Duty antibiotics: can a powerful combo beat dangerous infections faster?
NCT ID NCT07063095
Summary
This study is testing if adding a second antibiotic, called fosfomycin, to the standard treatment helps hospitalized adults with severe bacterial infections recover more quickly. Researchers will compare the two-drug combination against the standard single antibiotic to see if it leads to faster improvement in vital signs and reduces inflammation. The goal is to find a more effective treatment for serious infections like sepsis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAM NEGATIVE INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpitaux Universitaires de Genève
RECRUITINGGeneva, Canton of Geneva, 1205, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.